BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27913964)

  • 1. Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.
    Ravelli KG; Rosário BD; Camarini R; Hernandes MS; Britto LR
    Neurotox Res; 2017 Apr; 31(3):327-333. PubMed ID: 27913964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
    Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice.
    Wei YD; Chen XX; Yang LJ; Gao XR; Xia QR; Qi CC; Ge JF
    Neurochem Int; 2022 Oct; 159():105385. PubMed ID: 35843421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation.
    Fan M; Liu S; Sun HM; Ma MD; Gao YJ; Qi CC; Xia QR; Ge JF
    Biomed Pharmacother; 2022 Sep; 153():113375. PubMed ID: 35834993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
    Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
    Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
    Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
    J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin.
    Santos TO; Mazucanti CH; Xavier GF; Torrão AS
    Physiol Behav; 2012 Oct; 107(3):401-13. PubMed ID: 22921433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
    Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
    J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
    Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
    Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
    Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
    J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
    Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
    J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
    Ponce-Lopez T; Liy-Salmeron G; Hong E; Meneses A
    Brain Res; 2011 Dec; 1426():73-85. PubMed ID: 22036080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADPH oxidase contributes to streptozotocin-induced neurodegeneration.
    Ravelli KG; Rosário BDA; Vasconcelos AR; Scavone C; Camarini R; Hernandes MS; Britto LR
    Neuroscience; 2017 Sep; 358():227-237. PubMed ID: 28687315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.
    Yeo HG; Lee Y; Jeon CY; Jeong KJ; Jin YB; Kang P; Kim SU; Kim JS; Huh JW; Kim YH; Sim BW; Song BS; Park YH; Hong Y; Lee SR; Chang KT
    J Alzheimers Dis; 2015; 46(4):989-1005. PubMed ID: 25881906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
    Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
    Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
    Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chorionic gonadotropin decreases the phosphorylated tau protein level in streptozotocin-Alzheimeric male rats' hippocampus.
    Bahlakeh G; Jahanshahi M; Saeidi M
    Folia Neuropathol; 2018; 56(2):141-150. PubMed ID: 30509034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.